LOWELL, Mass., Jan. 28, 2020 /PRNewswire/ -- Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today four new members to their Scientific Advisory Board (SAB) who are leaders in the field infectious disease research and influenza vaccines: Drs. Frederick G. Hayden, Stacey Schultz-Cherry, David Topham and Ralph Tripp. According to the Centers for Disease Control (CDC), influenza vaccines were 29% effective during the 2017-2018 season due to the emergence of new, late season viral strains, contributing to an estimated 45 million influenza illnesses and 61,000 influenza-associated deaths...
|
